Mark Sims is the Vice President and Global Franchise Head of the AstraZeneca Oncology Business Unit, currently focusing on advancing healthcare innovation for cancer treatment. With over 20 years of experience in the bio-pharmaceutical sector, Mark has held various significant roles, including Senior Director at Idenix Pharmaceuticals and Vice President at Novartis, where they directed global strategies for breast cancer and hematology. Mark began their career as a Product Manager at Merck & Co. and has consistently contributed to cross-functional leadership and operational marketing. They earned an MBA from Thunderbird School of Global Management and a Bachelor of Commerce from McMaster University.
This person is not in any teams
This person is not in any offices